pubrio
Skyhawk Therapeutics

Skyhawk Therapeutics

United States · Biotechnology Research

Research

Pharmaceuticals

Biotechnology

Medical Research

Biotechnology Research

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

Company Insights
Company Overview

2016

Founded

Biotechnology Research

Industry

United States

Location

1,753,165

Ranking

66 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Skyhawk Therapeutics

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​